Commercial Calprotectin Immunoassays Show Discrepancies and Underestimate Severe Autoinflammation
A comparative evaluation reveals that commercial serum calprotectin immunoassays exhibit substantial proportional bias and vulnerability to high-dose hook effects despite ...

